| Men (n = 6276) | Women (n = 6236) | |
|---|---|---|
| Age, mean (SD) | 63.1 (12.9) | 65.1 (14.1) |
| Smoking status, n (%) | ||
| Current | 1168 (22.3) | 815 (15.4) |
| Never | 1583 (30.2) | 3069 (57.9) |
| Former | 2489 (47.5) | 1418 (26.7) |
| 10-year cardiovascular disease risk, n (%) | ||
| Low (<10%) | 146 (3.5%) | 364 (8.1%) |
| Intermediate (10%–20%) | 173 (4.1%) | 563 (12.6%) |
| High (>20%) | 3888 (92.4%) | 3548 (79.3%) |
| Known history of cardiovascular disease, n (%) | 1968 (31.4) | 1670 (26.8) |
| Known history of hypertension, n (%) | 3625 (57.8) | 3891 (62.4) |
| Measurement | ||
| HbA1c mmol/mol, mean (SD) | 54.6 (12.8) | 54.0 (11.6) |
| HbA1c %, mean (SD) | 7.2 (3.3) | 7.1 (3.2) |
| Systolic blood pressure, mmHg, mean (SD) | 137.9 (17.2) | 137.5 (18.0) |
| Diastolic blood pressure, mmHg, mean (SD) | 79.3 (10.1) | 78.5 (10.3) |
| Total cholesterol, mmol/l, mean (SD) | 4.4 (1.0) | 4.7 (1.0) |
| LDL-c, mmol/l, mean (SD) | 2.4 (0.8) | 2.6 (0.9) |
| HDL-c, mmol/l, mean (SD) | 1.2 (0.3) | 1.4 (0.3) |
| Body mass index, kg/m2, mean (SD) | 29.1 (4.6) | 30.7 (6.0) |
| Glucose-lowering drugs, n (%) | 4475 (71.3) | 4209 (67.5) |
| Lipid-lowering drugs, n (%) | 3966 (63.2) | 3592 (57.6) |
| Antihypertensive drugs, n (%) | 4139 (65.9) | 4245 (68.1) |
Due to missing data, not all variables included add up to n = 6276 for men and n = 6236 for women. HDL-c = high-density liproprotein cholesterol. LDL-c = low-density liproprotein cholesterol. SD = standard deviation.